The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.

Fifty health centers in Massachusetts, which serve a million patients a year, are straining under an "assault" from federal ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the 340B Drug Pricing Program. The complaint claims Amgen bypassed federal ...

The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...

The Trump administration kicked off another round of Medicare drug price negotiations, while Kaiser Permanente agrees to pay ...

The Trump administration on Tuesday announced the next round of prescription drugs up for Medicare price negotiations.

Still, the medications in the latest round of negotiations — which now includes “Part B” drugs given in doctors offices — ...

List includes medications for diabetes, cancer, arthritis, and more ...

CMS's third drug negotiation cycle under the IRA targets high-expenditure drugs, impacting Medicare Part B and D spending. The list includes drugs for cancer, HIV, and diabetes, with significant ...

The 15 drugs selected for negotiation include Eli Lilly’s breast-cancer drug Verzenio.

Medicare will negotiate prices for Part B injectable drugs for the first time, aiming to lower costs for millions of patients ...

CMS has announced that the new cycle of drug price negotiations by Medicare will include big-name drugs for diabetes and HIV/AIDS, as well as Botox injections. 1,2 The 15 high-cost prescription drugs ...